APPLICATION
BLA761497
TYPE
BLA
ORIGINAL APPROVAL
2026-07-24
LATEST ACTION
2026-07-24
ROUTE
MULTIDOSE, PREFILLED
DOSAGE FORM
VIAL, PEN
MARKETING STATUS
Prescription
Products
GARZULYSPrescription
INSULIN ASPART-FSAN 10ML · VIAL · MULTIDOSE
GARZULYSPrescription
INSULIN ASPART-FSAN 3ML · PEN · PREFILLED
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.